Department of Internal Medicine, University of Bonn, Bonn, Germany.
J Hepatol. 2011 Dec;55(6):1201-6. doi: 10.1016/j.jhep.2011.03.011. Epub 2011 Apr 13.
BACKGROUND & AIMS: The CCR5Δ32 mutation has been suspected to adversely affect outcomes of HCV infection, although reports have remained controversial. Here, we investigated the relative genetic contributions of the CCR5Δ32 deletion and the IL28B rs12979860 polymorphisms to spontaneous clearance of hepatitis C in a single-source outbreak.
We retrieved 396 Caucasian women (119 women with spontaneous HCV clearance) who had been infected with HCV genotype 1-contaminated anti-D immunoglobulin in 1978, and determined their IL28B and CCR5 alleles.
IL28B CC, CT, and TT genotypes were found in 35.4%, 50%, and 14.6% of patients and corresponded to spontaneous clearance rates of 50%, 21.2%, and 12.1% (Chi(2)=38.7, p=5.0×10(-10)), respectively. CCR5 WT/WT, WT/Δ32, and Δ32/Δ32 genotypes were observed in 76%, 22.7%, and 1.3% of patients and corresponded to clearance rates of 33.2%, 21.2%, and 0% (Chi(2)=6.9, p=0.009), respectively. In a stepwise forward-conditional multivariate regression model both CCR5 (OR 2.1, p=0.01 for WT/WT) and IL28B genetic variants (OR 4.3, p=4.6×10(-10) for the C/C genotype) were identified as independent predictors of spontaneous HCV clearance. Importantly, favorable response rates were associated with the IL28B CC genotype only in CCR5 wild-type homozygous women, while HCV clearance in CCR5Δ32 carriers remained poor even in patients with the rs12979860 CC genotype.
Both IL28B rs1297860 and CCR5Δ32 allelic variants are independent genetic determinants of spontaneous HCV clearance. The variable relative distribution between IL28B rs1297860 and CCR5Δ32 allelic variants in different populations may have masked the role of the CCR5Δ32 mutation in some studies.
CCR5Δ32 突变被怀疑会对 HCV 感染的结果产生不利影响,尽管相关报道仍存在争议。在此,我们对同一来源的 HCV 感染爆发中 CCR5Δ32 缺失和 IL28B rs12979860 多态性对自发清除 HCV 的相对遗传贡献进行了研究。
我们检索了 1978 年因输注抗-D 免疫球蛋白而感染 HCV 基因 1 型的 396 例高加索裔女性(119 例患者自发清除 HCV),并确定了她们的 IL28B 和 CCR5 等位基因。
35.4%、50%和 14.6%的患者分别携带 IL28B CC、CT 和 TT 基因型,相应的自发清除率分别为 50%、21.2%和 12.1%(Chi(2)=38.7,p=5.0×10(-10))。76%、22.7%和 1.3%的患者分别携带 CCR5 WT/WT、WT/Δ32 和 Δ32/Δ32 基因型,相应的清除率分别为 33.2%、21.2%和 0%(Chi(2)=6.9,p=0.009)。在逐步向前条件多元回归模型中,CCR5(WT/WT 基因型的 OR 为 2.1,p=0.01)和 IL28B 遗传变异(C/C 基因型的 OR 为 4.3,p=4.6×10(-10))均被确定为自发清除 HCV 的独立预测因子。重要的是,仅在 CCR5 野生型纯合子女性中,IL28B CC 基因型与有利的反应率相关,而 CCR5Δ32 携带者的 HCV 清除率即使在 rs12979860 CC 基因型患者中仍然较差。
IL28B rs1297860 和 CCR5Δ32 等位基因变异均为自发清除 HCV 的独立遗传决定因素。不同人群中 IL28B rs1297860 和 CCR5Δ32 等位基因变异的相对分布不同,这可能掩盖了 CCR5Δ32 突变在某些研究中的作用。